These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 14601158)

  • 1. Estimating the marginal value of 'better' research output: 'designed' versus 'routine' data in randomised controlled trials.
    Cohen D; Longo MF; Williams J; Cheung WY; Hutchings H; Russell IT
    Health Econ; 2003 Nov; 12(11):959-74. PubMed ID: 14601158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can randomised trials rely on existing electronic data? A feasibility study to explore the value of routine data in health technology assessment.
    Williams JG; Cheung WY; Cohen DR; Hutchings HA; Longo MF; Russell IT
    Health Technol Assess; 2003; 7(26):iii, v-x, 1-117. PubMed ID: 14499049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Globally optimal trial design for local decision making.
    Eckermann S; Willan AR
    Health Econ; 2009 Feb; 18(2):203-16. PubMed ID: 18435429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies.
    O'Hagan A; Stevens JW
    Stat Methods Med Res; 2002 Dec; 11(6):469-90. PubMed ID: 12516985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expected value of information and decision making in HTA.
    Eckermann S; Willan AR
    Health Econ; 2007 Feb; 16(2):195-209. PubMed ID: 16981193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of information analyses of economic randomized controlled trials: the treatment of intermittent claudication.
    Groot Koerkamp B; Spronk S; Stijnen T; Hunink MG
    Value Health; 2010; 13(2):242-50. PubMed ID: 19818058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pragmatic randomized controlled trials as a source of data in the assessment of effectiveness of medical technology].
    Kaczyński L; Solnica B
    Przegl Lek; 2012; 69(9):703-7. PubMed ID: 23401993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using routine data to complement and enhance the results of randomised controlled trials.
    Lewsey JD; Leyland AH; Murray GD; Boddy FA
    Health Technol Assess; 2000; 4(22):1-55. PubMed ID: 11074392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can electronic routine data act as a surrogate for patient-assessed outcome measures?
    Hutchings HA; Cheung WY; Williams JG; Cohen D; Longo MF; Russell I
    Int J Technol Assess Health Care; 2005; 21(1):138-43. PubMed ID: 15736526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of information methods for planning and analyzing clinical studies optimize decision making and research planning.
    Willan AR; Goeree R; Boutis K
    J Clin Epidemiol; 2012 Aug; 65(8):870-6. PubMed ID: 22609138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing willingness-to-pay: bidding game format versus open-ended and payment scale formats.
    Frew EJ; Wolstenholme JL; Whynes DK
    Health Policy; 2004 Jun; 68(3):289-98. PubMed ID: 15113640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating dynamic treatment strategies: does it have to be more costly?
    Buyze J; Goetghebeur E
    Pharm Stat; 2013; 12(1):35-42. PubMed ID: 23208788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.
    Siebert U; Rochau U; Claxton K
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(9-10):575-84. PubMed ID: 24315327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trials and tribulations. Emerging issues in designing economic evaluations alongside clinical trials.
    Coyle D; Davies L; Drummond MF
    Int J Technol Assess Health Care; 1998; 14(1):135-44. PubMed ID: 9509801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraclass correlation coefficient and outcome prevalence are associated in clustered binary data.
    Gulliford MC; Adams G; Ukoumunne OC; Latinovic R; Chinn S; Campbell MJ
    J Clin Epidemiol; 2005 Mar; 58(3):246-51. PubMed ID: 15718113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial and economic evaluation.
    Jain S; Arora NK
    Indian J Pediatr; 2000 May; 67(5):363-8. PubMed ID: 10885210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness research in radiology.
    Hunink MG
    Acad Radiol; 1996 Apr; 3 Suppl 1():S13-6. PubMed ID: 8796498
    [No Abstract]   [Full Text] [Related]  

  • 19. Alternative Weighting Approaches for Anchored Matching-Adjusted Indirect Comparisons via a Common Comparator.
    Petto H; Kadziola Z; Brnabic A; Saure D; Belger M
    Value Health; 2019 Jan; 22(1):85-91. PubMed ID: 30661638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discussion of papers on cost and efficiency of data collection in clinical trials.
    Ellenberg SS
    Stat Med; 1990; 9(1-2):145-8; discussion 148-51. PubMed ID: 2345831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.